Krystal Biotech Inc — Cash Flow (NASDAQ:KRYS) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -26.08 M-47.94 M-100.57 M-88.8 M123.42 M200.87 M 200.87 M Cash from investing activities -11.18 M-226.77 M-114.08 M82.64 M-163.44 M-58.42 M -58.42 M Cash from financing activities 118.02 M347.69 M35.35 M202.75 M27.01 M8.71 M 8.71 M Free cash flow -40.93 M-116.27 M-153.55 M-100.6 M119.18 M188.91 M 188.91 M

News

OCGN Gene-Agnostic Eye Therapy Could Shift Retinal Drug Development

Ocugen Stock Outlook: Balancing Cash Burn and Late-Stage Data

OCGN Gene Therapy Pipeline: 2026-2027 Catalysts To Watch

Why Is Krystal Biotech (KRYS) Down 11.5% Since Last Earnings Report?

Krishnan Krish S, president of Krystal Biotech, sells $6.58 million in KRYS stock

Krystal Biotech director Krishnan sells $6.58 million in shares

Krystal Biotech at TD Cowen Conference: Strategic Growth and Challenges

Daniel Janney sells Krystal Biotech (KRYS) shares worth $3.25 million

Krystal Biotech director Janney sells shares worth $10.1 million

Krystal Biotech (KRYS) director Rossi sells shares worth $4.95 million

AI Play SPX Leads 17 Top Performers Onto Best Stock Screens Like IBD 50, Stock Spotlight, More

Krystal Biotech Q4 Earnings Beat Estimates, Revenues Miss Mark